Stock Research: Bausch Health Companies

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Bausch Health Companies

TOR:BHC CA0717341071
49
  • Value
    98
  • Growth
    13
  • Safety
    Safety
    78
  • Combined
    79
  • Sentiment
    11
  • 360° View
    360° View
    49
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Bausch Health Companies Inc. is a global specialty pharmaceutical and medical device company. It operates in the pharmaceutical and medical device industries, with brands like Bausch + Lomb. It operates globally, including the U.S. and internationally. In the last fiscal year, the company had a market cap of $2378 million, profits of $6843 million, and revenue of $9625 million, with 20700 employees.

more
Index
TSX Composite
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
98 100 100 100
Growth
13 17 43 47
Safety
Safety
78 39 26 8
Sentiment
11 10 28 14
360° View
360° View
49 21 37 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
1 1 5 53
Opinions Change
50 28 75 35
Pro Holdings
n/a 76 91 74
Market Pulse
4 1 3 2
Sentiment
11 10 28 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
98 100 100 100
Growth
13 17 43 47
Safety Safety
78 39 26 8
Combined
79 55 62 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
100 95 95 84
Price vs. Earnings (P/E)
100 96 100 100
Price vs. Book (P/B)
95 96 95 98
Dividend Yield
1 1 1 1
Value
98 100 100 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
32 24 38 21
Profit Growth
60 50 49 34
Capital Growth
6 25 42 79
Stock Returns
27 39 65 73
Growth
13 17 43 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
7 7 5 9
Refinancing
88 65 69 5
Liquidity
71 53 49 61
Safety Safety
78 39 26 8

Similar Stocks

Discover high‑ranked alternatives to Bausch Health Companies and broaden your portfolio horizons.

Trican

TOR:TCW
Country: Canada
Industry: Oil & Gas Equipment
Size: Medium
Full Stock Analysis

B2Gold

TOR:BTO
Country: Canada
Industry: Gold Production
Size: Large
Full Stock Analysis

Parex Resources

TOR:PXT
Country: Canada
Industry: Oil & Gas Production
Size: Medium
Full Stock Analysis

Harmony Biosciences Holdings

NMQ:HRMY
Country: USA
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only strength is good value. All other factors (growth, safety, and sentiment) are below average. This stock is highly sensitive to a crisis and is not advisable. Avoid unless you have solid, independent reasons to believe a significant turnaround is imminent.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: